# Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases

> **NCT04530461** · — · UNKNOWN · sponsor: **faida agili** · enrollment: 200 (estimated)

## Conditions studied

- SARS-CoV Infection
- Systemic Disease
- Systemic Lupus Erythematosus
- Sjogren's Syndrome
- Sarcoidosis
- Inflammatory Myopathy
- Behçet Disease
- Rheumatoid Arthritis
- Spondyloarthritis

## Interventions

- **DIAGNOSTIC_TEST:** Serological test

## Key facts

- **NCT ID:** NCT04530461
- **Lead sponsor:** faida agili
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2020-11-30
- **Final completion:** 2021-01-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530461, "Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04530461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*